Archive for February 2022

After partnerships with PepsiCo and Gatorade, the Cambridge-based startup raised $10M for its patches that measure biomarkers in sweat. Read More

Verge Genomics, which is coupling human brain disease data with artificial intelligence and machine learning, looks to take its first drug into a clinical trial this year against amyotrophic lateral sclerosis. Read More

While some in the life sciences industry create drugs and devices to tackle the Covid-19 pandemic, their colleagues are busy as ever raising money, testing new drugs, expanding facilities and more. Read More

Good morning, Boston. Here are the five things you need to know to start your busy workday, plus Covid test reimbursements, a new Fed president and hiring the wrong person. Read More

The Massachusetts Association of Realtors and the Greater Boston Real Estate Board sent a letter this week to legislators arguing against bills that would let municipalities impose the fee on expensive transactions to fund affordable housing. Read More

The construction of a 1.68-million-square-foot mixed-use development will be no simple task, just as the project’s path to city approval last year was a complicated one. Read More

The decision comes more than four months after long-time Boston Fed leader Eric Rosengren stepped down. Read More

Under a new oversight board, MBTA leadership seems to have abandoned the idea of fare equity entirely, at least under its newest proposal for fare changes. Read More

Bus fares on three MBTA routes servicing riders in Dorchester, Mattapan and Roxbury will be eliminated for two years starting March 1. Read More